Meta-analysis: Incidence of cirrhosis and hepatocellular carcinoma in patients with Fontan palliation.
Asif Ali HitawalaHarish GopalakrishnaMaria MironovaAlicia A LivinskiElizabeth C WrightTacy DowningSeiji ItoStacy D FisherAri M CedarsAnitha S JohnTheo HellerPublished in: Alimentary pharmacology & therapeutics (2024)
The incidence of cirrhosis and HCC increases over time, especially at ≥20 years post Fontan surgery. Studies are needed to further identify at-risk patients in order to streamline surveillance for these highly morbid conditions.
Keyphrases
- systematic review
- end stage renal disease
- risk factors
- ejection fraction
- newly diagnosed
- minimally invasive
- public health
- chronic kidney disease
- case control
- prognostic factors
- peritoneal dialysis
- bariatric surgery
- coronary artery bypass
- randomized controlled trial
- acute coronary syndrome
- atrial fibrillation
- percutaneous coronary intervention
- surgical site infection